Results 111 to 120 of about 30,870 (207)

A Common Language for the Multidisciplinary Team: Point‐of‐Care Musculoskeletal Ultrasound in Modern Haemophilia Care

Haemophilia, EarlyView.
ABSTRACT The evolving haemophilia care landscape has evolved with personalised prophylaxis, new coagulation factor molecules, non‐replacement therapies, and gene therapy, leading to significantly reduced bleeding frequency and haemophilic arthropathy burden.
Hortensia De la Corte‐Rodriguez, María Teresa Álvarez‐Román, Mauro Davoli, Magnus Aspdahl, Christina Burgess, Karin Fijinvandraat, Roberta Gualtierotti, Cedric Hermans, Marko Marinić, Carlo Martinoli, Wolfgang Miesbach, Gianluigi Pasta, Michael Sigl‐Kraetzig, David Stephensen, Malin Svennefalk, Víctor Jiménez‐Yuste, the E.A.H.A.D. Joint Health Group   +16 more
wiley   +1 more source

Pediatric Rheumatology – a continuation of Pediatric Rheumatology Online Journal

Pediatric Rheumatology Online Journal, 2007
Spencer Charles H, Martini Alberto
doaj   +1 more source

Advancements in Diagnosis and Care for Immune Dysregulation and Inborn Errors of Immunity in Pediatric Rheumatology: Our 50-Year Journey. [PDF]

Arthritis Care Res (Hoboken)
Day-Lewis M, Cheng JL, Behrens E, Hazen MM, Janssen EM, Lee PY, Vogel TP, Volpi S, Cooper MA, Canna SW, Henderson LA.   +10 more
europepmc   +1 more source

Prevalence and Risk Factors of Systemic Lupus Erythematosus in Patients With Chronic Cutaneous Lupus: A Bicentric Study Employing Three Classification Criteria

International Journal of Dermatology, EarlyView.
This bicentric study of 95 CCLE patients shows SLE prevalence (21.1%–31.6%) varies significantly by classification criteria. Arthralgia was a consistent independent risk factor across all systems. Our findings support the implementation of systematic risk‐stratified screening protocols for CCLE patients, with particular attention to joint symptoms and ...
Noureddine Litaiem, Syrine Nahali, Maroua Slouma, Mourad Mokni, Faten Zeglaoui   +4 more
wiley   +1 more source

A novel score for transition success of pediatric rheumatology patients. [PDF]

Health Care Transit
Blasingame K, McDonald D, Gillispie-Taylor M, Vogel TP.   +3 more
europepmc   +1 more source

The Effect of PTPN22 Polymorphism on Juvenile Idiopathic Arthritis Subtypes and Disease Activity in a Finnish Study Population

International Journal of Immunogenetics, EarlyView.
ABSTRACT Genetic factors that modulate immune regulation are increasingly recognised as contributors to the heterogeneity and clinical course of autoimmune diseases. Polymorphisms of protein tyrosine phosphatase non‐receptor type 22 (PTPN22) are associated with several autoimmune diseases.
Sonja Kvist, Johanna Teräsjärvi, Heidi Rahikkala, Jussi Mertsola, Milja Möttönen, Qiushui He   +5 more
wiley   +1 more source

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study. [PDF]

Pediatr Rheumatol Online J
Gezgin Yıldırım D, Küçükali B, Akay N, Yoğun SN, Tunce E, Taştanoğlu H, Doğru A, Bayrak YE, Şener S, Erkan MO, Torun R, Ayduran S, Kocamaz NG, Küçük E, Akın OA, Yıldız Ç, Aslan E, Demirkan FG, Kasap Demir B, Kışla Ekinci RM, Yüksel S, Türkuçar S, Sağ E, Şahin N, Çelikel E, Öztürk K, Ozdel S, Paç Kısaarslan A, Aktay Ayaz N, Sözeri B, Ünsal E, Kasapçopur Ö, Bakkaloğlu SA.   +32 more
europepmc   +1 more source

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This international, multicentre real‐world study of 148 patients’ documents treatment‐associated, bidirectional phenotype switching between psoriasis and atopic dermatitis. Psoriasis‐to‐eczematous switches occurred predominantly with IL‐17 and IL‐23 inhibitors, whereas AD‐to‐psoriasiform switches occurred exclusively during treatment with biologic ...
Tiago Torres, Mario Valenti, Anna Balato, Matteo Megna, Paolo Gisondi, Vimal Prajapati, Stefano Piaserico, Julia‐Tatjana Maul, Lara Valeska Maul, Jose Manuel Carrascosa, Francisco José Navarro‐Triviño, Elizabeth Lazaridou, César Ferreira, Jacopo Tartaglia, Christian Ciolfi, Athina‐Ioanna Daponte, Eugenia Veronica Di Brizzi, Maddalena Napolitano, Barbara Leal Guerra, Monica Munera‐Campos, Siddhartha Sood, Silvia Ferruci, Francesca Prignano, Esteban Dauden, Mar Llamas‐Velasco, Ron Vender, Jensen Yeung, Angelo Marzano, Luis Puig   +28 more
wiley   +1 more source

TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan. [PDF]

Pediatr Rheumatol Online J
Wakiguchi H, Hashimoto K, Yashiro M, Nishimura K, Ebato T, Akamine K, Uejima Y, Sato T, Yamasaki Y, Yasumura J, Okazaki F, Kizawa T, Yasuoka R, Ishikawa T, Yamamoto T, Fujita Y, Itoh N, Takasaki A, Sakurai N, Suzuki K, Tamai T, Hirano N, Okamoto N, Shimizu M.   +23 more
europepmc   +1 more source

Measuring success in HS treatment from the physician's and the patient's perspective

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis, Monika Arenbergerova, Zeljko Mijuskovic, Baoxi Wang, Christos C. Zouboulis   +4 more
wiley   +1 more source